Targeting SLK protects against cerebral ischemia–reperfusion injury by regulating USP8-mediated HIF-1α stabilization and RhoA/ROCK activation
Open Access
- 1 July 2026
- journal article
- Published by Springer Nature in Cellular & Molecular Biology Letters
- Vol. 31 (1)
Abstract
Introduction: Acute ischemic stroke (AIS) represents a major global contributor to mortality and chronic disability, with few effective therapeutic targets available. Identifying druggable genes associated with AIS is therefore critical for developing novel interventions. Methods: A comprehensive approach combining Mendelian randomization, multi-omics integration, and machine learning was employed to identify candidate druggable genes. Causal relationships were confirmed through genetic colocalization, and candidate genes were further validated in a retrospective clinical cohort comprising 60 patients who experienced AIS and 30 healthy controls. Functional and mechanistic investigations were performed using a male mouse middle cerebral artery occlusion/reperfusion (MCAO/R) model, oxygen–glucose deprivation/reperfusion (OGD/R) in HT22 cells, and 293 T cells. Results: SLK emerged as a genetically causal AIS gene and a central component of the optimal predictive model. Plasma SLK levels were elevated in patients who experienced AIS, demonstrating strong diagnostic and prognostic value and serving as an independent predictor of unfavorable 3-month outcomes after adjusting for age, sex, and baseline National Institutes of Health Stroke Scale (NIHSS) score. Knockdown of SLK conferred neuroprotection both in vivo and in vitro. SLK interacted with and phosphorylated the deubiquitinase USP8, increasing its activity and suppressing K48-linked polyubiquitination and degradation of HIF-1α. HIF-1α was stabilized following activation of the RhoA/ROCK signaling pathway, aggravating ischemic injury, whereas USP8 overexpression mitigated the neuroprotective effects of SLK knockdown. Conclusions: These findings identify SLK as a neuron-specific proischemic factor and a potential therapeutic target, elucidate the SLK–USP8–HIF-1α–RhoA/ROCK pathway as a key mechanistic pathway, and highlight plasma SLK as a promising diagnostic and prognostic biomarker with translational relevance.Keywords
Funding Information
- National Natural Science Foundation of China (82301645)
- General Project of Chongqing Natural Science Foundation (CSTB2025NSCQ-GPX0295)
- China Postdoctoral Science Foundation funded project (2024MD764053)
- Chongqing Technology Innovation and Application Development Project (CSTB2022TIAD-KPX0160)
- Joint Project of Pinnacle Disciplinary Group, the Second Affiliated Hospital of Chongqing Medical University (JJCSZD-202503)
- Joint Project of Pinnacle Disciplinary Group, the Second Affiliated Hospital of Chongqing Medical University (JJCSQN-202503)
- Joint Project of Chongqing Health Commission and Science and Technology Bureau (2026MSXM009)
This publication has 67 references indexed in Scilit:
- Nanoparticles Designed Based on the Blood‐Brain Barrier for the Treatment of Cerebral Ischemia‐Reperfusion InjurySmall, 2025
- DDR1 Drives Malignant Progression of Gastric Cancer by Suppressing HIF‐1α Ubiquitination and DegradationAdvanced Science, 2024
- Applications of multi‐omics analysis in human diseasesMedcomm, 2023
- Targeting p53 for neuroinflammation: New therapeutic strategies in ischemic strokeJournal of Neuroscience Research, 2023
- Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implicationsMedicinal Research Reviews, 2021
- Anti-cerebral ischemia reperfusion injury of polysaccharides: A review of the mechanismsBiomedicine & Pharmacotherapy, 2021
- Muscle-specific deletion of SLK/Stk2 enhances p38 activity and myogenesis in mdx miceBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2021
- Folic Acid Exerts Post-Ischemic Neuroprotection In Vitro Through HIF-1α StabilizationMolecular Neurobiology, 2018
- HIF1α deubiquitination by USP8 is essential for ciliogenesis in normoxiaEMBO Reports, 2013
- Extracellular adenosine signaling in molecular medicineJournal of Molecular Medicine, 2013